News

The global community has committed to the Triple Elimination of mother-to-child transmission (EMTCT) of HIV, syphilis and ...
Why a twice‑yearly injection might prove to be a good shot Lenacapavir is a first-in-class HIV drug that works by targeting ...
Rwanda is among the countries interested in Lenacapavir, a newly approved, long-acting preventive injection, though its cost is seemingly out of reach for many developing countries.
Younger children living with HIV with low BMI for their age were more likely than older children to fail first-line ...
The Trump administration's halted funding to the President's Emergency Plan for AIDS Relief (PEPFAR) and dissolution of the U.S. Agency for International Development (USAID) have had devastating ...